Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genetic Testing Solutions > PGT-M

PGT-M Preimplantation Genetic Testing for Monogenic disorders

Prevent the transmission of single gene disorders to future children and achieve a healthy pregnancy

PGT-M Preimplantation Genetic Testing
  • Technical Overview
  • Documentation
  • Scientific evidence
  • I’m not a health specialist

Options for combined
PGT-M+PGT-A

Our PGT-M testing is 98% accurate

SAT: Sperm Aneuploidy Test

 300 diseases for which the PGT-M test is already developed

Interested in learning more?

Request information
Or Email us at supportspain@igenomix.com
Overview
  • PGT-M
  • Benefits
  • Indications

What is PGT-M test?

  • PGT-M (formerly PGD) is an early genetic diagnosis test for embryos produced during IVF, prior to their transfer to the uterus.
  • By analysing DNA from each embryo, normal embryos can be preferentially selected to be transferred and begin the journey towards conceiving a healthy child.

What is the procedure?

Why should use Preimplantation Genetic Testing for Monogenic disorders (PGT-M)

  • Higher chance of a healthy baby: It maximizes the chances of having a baby free from the disease for couples who have a high genetic risk.
  • Possibility of PGT-M + PGT-A: We can perform PGT-M and PGT-A for screening of aneuploidies in the same biopsy.
  • We can perform PGT-M for most monogenic disorders.
Download full disease list

Who should use PGT-M test?

  • Patients who are undergoing an assisted reproduction treatment and have a personal or familial high-risk for single gene conditions. This risk may be identified due to:
  • A family history of these conditions
  • A positive carrier screening result
  • A previous affected child
Download full disease list

Test limitations

  • Limitations of PGT-M can arise from the IVF treatment itself. For example, poor ovarian stimulation can reduce the likelihood of identifying a healthy embryo, since PGT-M success is linked to the number of high-quality eggs and embryos produced in the cycle.
  • Not all people who wish to have PGT-M are able to do so. It is essential that the disorder to be diagnosed has a comprehensive and accurate genetic characterization to at least identify the gene responsible for the condition. Regulatory restrictions (e.g. from the HFEA in the UK) may additionally limit which conditions can be tested.
  • PGT-M provides no guarantee of a completely healthy baby. If a couple is at high risk of transmitting a particular disease to their offspring, PGT-M significantly minimises this risk. However, there remains a small risk of misdiagnosis due to technical limitations, such as contamination, recombination and ADO. Couples should always be offered the possibility of prenatal diagnosis to confirm results. It is important to know that PGT-M will test for the specific mutation requested, but no other genes or mutations are analyzed, even if they are located within the same gene.
Documentation
  • PGT-M Specialists' documents

Clinical Sheets

Download

Brochure

Download

Instructions

Download
Scientific evidence

Relevant related studies:

G. Kakourou et al., The clinical utility of PGD with HLA matching a collaborative multi-centre ESHRE study. Human Reproduction, Vol.33, No.3 pp. 520–530. Fertility and Sterility

M De Rycke, et al., ESHRE PGD Consortium data collection XIV–XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013, Human Reproduction, Volume 32, Issue 10, October 2017, Pages 1974–1994.

FAQs

Opening hours, contact details, lab address...

User manual

If you're a little lost with this technical information...

Can we help you?

I’m not a health specialist

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

Learn more about Igenomix

Other services

CGT Carrier Genetic Test

CGT

Determines the risk of having a child with a genetic disease

More information
PGT-A Preimplantation Genetic Testing

PGT-A

Chromosomally normal
embryos selection

More information
NACE Non-invasive prenatal test

NACE

Minimizes unnecessary amniocentesis

More information

Igenomix is in the media

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information